Skip Anthem, Express Scripts Drug Price Fight, US Tells Justices

May 25, 2022, 2:58 PM UTC

A case asking whether insurers and pharmacy benefit managers face ERISA liability when negotiating drug prices doesn’t merit US Supreme Court review, according to a federal government brief advising the justices to skip a case involving Anthem Inc. and Express Scripts Inc.

The US Court of Appeals for the Second Circuit’s 2020 decision declining to hold either company liable as a fiduciary under the Employee Retirement Income Security Act is a nonprecedential ruling that doesn’t conflict with any Supreme Court or appeals court decisions, US Solicitor General Elizabeth B. Prelogar told the justices in a brief filed Tuesday.

However Prelogar’s ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.